Proteasome Inhibition Increases Recruitment of IκB Kinase β (IKKβ), S536P-p65, and Transcription Factor EGR1 to Interleukin-8 (IL-8) Promoter, Resulting in Increased IL-8 Production in Ovarian Cancer Cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Proteasome Inhibition Increases Recruitment of IκB Kinase β (IKKβ), S536P-p65, and Transcription Factor EGR1 to Interleukin-8 (IL-8) Promoter, Resulting in Increased IL-8 Production in Ovarian Cancer Cells
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 289, Issue 5, Pages 2687-2700
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2013-12-12
DOI
10.1074/jbc.m113.502641
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Proteasome Inhibition by Bortezomib Increases IL-8 Expression in Androgen-Independent Prostate Cancer Cells: The Role of IKK
- (2013) S. Manna et al. JOURNAL OF IMMUNOLOGY
- Non-Steroidal Anti-inflammatory Drugs Decrease E2F1 Expression and Inhibit Cell Growth in Ovarian Cancer Cells
- (2013) Blanca L. Valle et al. PLoS One
- Non-steroidal anti-inflammatory drug use and ovarian cancer risk: findings from the NIH-AARP Diet and Health Study and systematic review
- (2012) Megan A. Murphy et al. CANCER CAUSES & CONTROL
- IKK- Coordinates Invasion and Metastasis of Ovarian Cancer
- (2012) S. Hsu et al. CANCER RESEARCH
- NF-κB and chromatin: ten years on the path from basic mechanisms to candidate drugs
- (2012) Gioacchino Natoli IMMUNOLOGICAL REVIEWS
- IKK biology
- (2012) Fei Liu et al. IMMUNOLOGICAL REVIEWS
- Dimer-specific regulatory mechanisms within the NF-κB family of transcription factors
- (2012) Stephen T. Smale IMMUNOLOGICAL REVIEWS
- Site-specific Phosphorylation of the p65 Protein Subunit Mediates Selective Gene Expression by Differential NF-κB and RNA Polymerase II Promoter Recruitment
- (2012) Karin Hochrainer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of an N-terminal Truncation of the NF-κB p65 Subunit That Specifically Modulates Ribosomal Protein S3-dependent NF-κB Gene Expression
- (2012) Eric M. Wier et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Promotion of DNA repair by nuclear IKKβ phosphorylation of ATM in response to genotoxic stimuli
- (2012) K Sakamoto et al. ONCOGENE
- The Immunoproteasome as a Target in Hematologic Malignancies
- (2012) Deborah J. Kuhn et al. SEMINARS IN HEMATOLOGY
- Bortezomib Induces Nuclear Translocation of I B Resulting in Gene-Specific Suppression of NF- B-Dependent Transcription and Induction of Apoptosis in CTCL
- (2011) A. Juvekar et al. MOLECULAR CANCER RESEARCH
- Combinatorial Effect of Non-Steroidal Anti-inflammatory Drugs and NF-κB Inhibitors in Ovarian Cancer Therapy
- (2011) Luiz F. Zerbini et al. PLoS One
- Regulation of Inflammation by the NF-κB Pathway in Ovarian Cancer Stem Cells
- (2010) Aliza L. Leizer et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Nuclear factor κB transcription factors are coexpressed and convey a poor outcome in ovarian cancer
- (2010) Christina M. Annunziata et al. CANCER
- Activation of NF- B Signaling by Inhibitor of NF- B Kinase Increases Aggressiveness of Ovarian Cancer
- (2010) L. Hernandez et al. CANCER RESEARCH
- Targeting transcription factor NFκB: comparative analysis of proteasome and IKK inhibitors
- (2010) Alexander V. Gasparian et al. CELL CYCLE
- Metabolism and Action of Proteasome Inhibitors in Primary Human Hepatocytes
- (2010) C.-M. Lee et al. DRUG METABOLISM AND DISPOSITION
- Proteasome Inhibitor PS-341 (Bortezomib) Induces Calpain-dependent IκBα Degradation
- (2010) Chunyang Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Gene-Specific Repression of Proinflammatory Cytokines in Stimulated Human Macrophages by Nuclear I B
- (2010) C. C. Ghosh et al. JOURNAL OF IMMUNOLOGY
- Nuclear IKKβ Is an Adaptor Protein for IκBα Ubiquitination and Degradation in UV-Induced NF-κB Activation
- (2010) Yoshihiro Tsuchiya et al. MOLECULAR CELL
- Copper Transporters and the Cellular Pharmacology of the Platinum-Containing Cancer Drugs
- (2010) S. B. Howell et al. MOLECULAR PHARMACOLOGY
- Specification of the NF-κB transcriptional response by p65 phosphorylation and TNF-induced nuclear translocation of IKKε
- (2010) Rita Moreno et al. NUCLEIC ACIDS RESEARCH
- Bortezomib induces canonical nuclear factor- B activation in multiple myeloma cells
- (2009) T. Hideshima et al. BLOOD
- Enhanced Delivery of Cisplatin to Intraperitoneal Ovarian Carcinomas Mediated by the Effects of Bortezomib on the Human Copper Transporter 1
- (2009) D. D. Jandial et al. CLINICAL CANCER RESEARCH
- A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: A Gynecologic Oncology Group study
- (2009) Carol Aghajanian et al. GYNECOLOGIC ONCOLOGY
- Targeted Knockdown of EGR-1 Inhibits IL-8 Production and IL-8-mediated Invasion of Prostate Cancer Cells through Suppressing EGR-1/NF-κB Synergy
- (2009) Jiajia Ma et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Proteasome inhibitors in the treatment of multiple myeloma
- (2009) J J Shah et al. LEUKEMIA
- Proteasome inhibition represses ERα gene expression in ER+ cells: a new link between proteasome activity and estrogen signaling in breast cancer
- (2009) G L Powers et al. ONCOGENE
- Proteasome inhibitors induce apoptosis of prostate cancer cells by inducing nuclear translocation of IκBα
- (2008) Hai-Yen Vu et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Shared Principles in NF-κB Signaling
- (2008) Matthew S. Hayden et al. CELL
- The Interleukin-8 Pathway in Cancer
- (2008) D. J.J. Waugh et al. CLINICAL CANCER RESEARCH
- Mechanisms of proteasome inhibitor action and resistance in cancer
- (2008) David J. McConkey et al. DRUG RESISTANCE UPDATES
- Transcriptional Regulation ofEGR-1by the Interleukin-1-JNK-MKK7-c-Jun Pathway
- (2008) Elke Hoffmann et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regulation of IKKβ by miR-199a affects NF-κB activity in ovarian cancer cells
- (2008) R Chen et al. ONCOGENE
- Phase I trial of the proteasome inhibitor bortezomib in combination with carboplatin in patients with platinum- and taxane-resistant ovarian cancer
- (2007) Pedro T. Ramirez et al. GYNECOLOGIC ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started